Alejandro Garcia-Alvarez
7PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 04, 2026
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.Jaume Capdevila, Jorge Hernando, Javier Molina-Cerillo
|Sep 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo
|May 23, 2023
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin.J Capdevila, J Hernando, A Teule
|Feb 16, 2022
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?Alejandro Garcia-Alvarez, Jorge Hernando Cubero, Jaume Capdevila
|Jul 02, 2021
Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies.Alejandro Garcia-Alvarez, Andri Papakonstantinou, Mafalda Oliveira
|Jun 01, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs.Louis de Mestier, Angela Lamarca, Jorge Hernando
Pageof 2
Frequent Collaborators
3 joint publications
Jaume Capdevila
2 joint publications
Alex Teulé
2 joint publications
Paolo Nuciforo
2 joint publications
Alberto Carmona-Bayonas
1 joint publications
G Crespo
1 joint publications
S Landolfi
1 joint publications
Jérôme Cros
1 joint publications
Andri Papakonstantinou
1 joint publications
Mafalda Oliveira
1 joint publications
Jorge Hernando
